NIDO-361

DRUG2 trials

Sponsors

Nido Biosciences Inc., Nido Biosciences, Inc.

Conditions

Kennedy's DiseaseSpinal and Bulbar Muscular Atrophy

Phase 2

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of NIDO-361 in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

CompletedCTIS2023-507128-22-00

Nido Biosciences Inc.Spinal and Bulbar Muscular Atrophy

Start: 2024-03-01End: 2025-10-22Target: 27Updated: 2025-09-16

A Study of NIDO-361 in Patients With SBMA

CompletedNCT06411912

Nido Biosciences, Inc.Kennedy's Disease, Spinal and Bulbar Muscular Atrophy

Start: 2024-03-01End: 2025-10-22Updated: 2026-03-03